Journal of Dermatological Treatment

Article	Citations
Minoxidil: a comprehensive review	75
Real-world practice indirect comparison between guselkumab, risankizumab, and tildrakizumab: results from an Italian 28-week retrospective study	58
Melasma treatment: a systematic review	44
Guselkumab is efficacious and safe in psoriasis patients who failed anti-IL17: a 52-week real-life study	43
Dupilumab in prurigo nodularis: a systematic review of current evidence and analysis of predictive factors to response	39
Efficacy, safety, and drug survival of IL-23, IL-17, and TNF-alpha inhibitors for psoriasis treatment: a retrospective study	34
Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia	32
Dupilumab for the treatment of adult atopic dermatitis in special populations	30
JAK inhibitors in lichen planus: a review of pathogenesis and treatments	26
Beneficial effect of Lactobacillus plantarum IS-10506 supplementation in adults with atopic dermatitis: a randomized controlled trial	25
Topical corticosteroid withdrawal (‘steroid addiction’): an update of a systematic review	25
A comprehensive review of platelet-rich plasma for the treatment of dermatologic disorders	25
Biologic treatment for psoriasis in cancer patients: should they still be considered forbidden?	24
Finasteride for hair loss: a review	24
Baricitinib improves symptoms in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: patient-reported outcomes from two randomized monotherapy phase	24
Antifungal resistance in superficial mycoses	23
Cosmetic skin lightening use and side effects	23
Soluble biomarkers for diagnosis, monitoring, and therapeutic response assessment in psoriasis	22
Quantifying patient preferences for systemic atopic dermatitis treatments using a discrete-choice experiment	22
Safety of baricitinib for the treatment of atopic dermatitis over a median of 1.6 years and up to 3.9 years of treatment: an updated integrated analysis of eight clinical trials	20
Risk of COVID-19 infection, hospitalization, and mortality in patients with psoriasis treated by interleukin-17 inhibitors	20
Biologic therapies for plaque type psoriasis in patients with previous malignant cancer: long-term safety in a single- center real-life population	20
Disease burden and treatment history among adults with atopic dermatitis receiving systemic therapy: baseline characteristics of participants on the EUROSTAD prospective observational study	19
Network meta-analysis comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis	19
Efficacy of guselkumab versus secukinumab in subpopulations of patients with moderate-to-severe plaque psoriasis: results from the ECLIPSE study	18

Guselkumab, tildrakizumab, and risankizumab in a real-world setting: drug survival and effectiveness in the treatment of psoriasis and psoriatic arthritis	18
Elevation of peripheral blood eosinophils during dupilumab treatment for atopic dermatitis is associated with baseline comorbidities and development of facial redness dermatitis and ocular surface dis	17
Generalized pustular psoriasis: the new era of treatment with IL-36 receptor inhibitors	16
Efficacy, safety, and drug survival of patients with psoriasis treated with IL-17 inhibitors – brodalumab, ixekizumab, and secukinumab: real-world data from the Czech Republic BIOREP registry	16
The prevention effect of probiotics against eczema in children: an update systematic review and meta-analysis	16
Upadacitinib for the treatment of concomitant psoriasis and atopic dermatitis: a case series	16
Efficacy of GLP-1rA, liraglutide, in plaque psoriasis treatment with type 2 diabetes: a systematic review and meta-analysis of prospective cohort and before-after studies	15
The impact of COVID-19 pandemic on psoriasis patients, and their immunosuppressive treatment: a cross-sectional multicenter study from Turkey	15
PASI 100 response rates in moderate to severe psoriasis: a systematic literature review and analysis of clinical practice guidelines	15
Treatment adherence and persistence of seven commonly prescribed biologics for moderate to severe psoriasis and psoriatic arthritis in a U.S. commercially insured population	15
The dark side of the moon: the immune-mediated adverse events of IL-17A/IL-17R inhibition	15
Real-world switching patterns and associated characteristics in patients with psoriasis treated with biologics in the United States	14
Deucravacitinib in the treatment of psoriasis	14
Artificial intelligence image recognition of melanoma and basal cell carcinoma in racially diverse populations	14
Dietary habits and perceptions of psoriatic patients: Mediterranean versus Asian diets	13
Laboratory safety of dupilumab for up to 3 years in adults with moderate-to-severe atopic dermatitis: results from an open-label extension study	13
Bullous pemphigoid induced by biologic drugs in psoriasis: a systematic review	13
Assessment of various intralesional injections in keloid: comparative analysis	13
Treatment of patients with chronic pruritus of unknown origin with dupilumab	12
Benefits, drawbacks, and challenges of social media use in dermatology: a systematic review	12
Baricitinib for the treatment of atopic dermatitis	12
New-onset and flares of psoriasis after COVID-19 infection or vaccination successfully treated with biologics: a case series	12
Lack of reactivation of tuberculosis in patients with psoriasis treated with secukinumab in a real-world setting of latent tuberculosis infection	12
Unmet needs in atopic dermatitis management: an expert consensus	12
Ustekinumab as adjuvant treatment for all pyoderma gangrenosum subtypes	11
Patient and caregiver preferences on treatment attributes for atopic dermatitis	11
Tralokinumab rapidly improves subjective symptoms and quality of life in patients with moderate-to-severe atopic dermatitis: a real-life 16-week experience	11
Dupilumab for the treatment of atopic dermatitis: real-world data from the Czech Republic BIOREP registry	11
Successful treatment of paediatric generalized pustular psoriasis with secukinumab: a case series	11
Pregnancy outcomes in patients with psoriasis, psoriatic arthritis, or axial spondyloarthritis receiving ixekizumab	11
Real-world evidence for ixekizumab in the treatment of psoriasis and psoriatic arthritis: literature review 2016–2021	11
Effectiveness of risankizumab in plaque psoriasis with involvement of difficult-to-treat areas: a real-world experience from two referral centers	11
The prevalence of SARS-CoV-2 infection and the severity of the course of COVID-19 in patients with psoriasis treated with biologic therapy	10
Effects of TNF inhibitors and an IL12/23 inhibitor on changes in body weight and adipokine levels in psoriasis patients: a 48-week comparative study	10
Dupilumab for atopic dermatitis: a real-world Portuguese multicenter retrospective study	10
Real-life experience with chlormethine gel for early-stage mycosis fungoides with emphasis on types and management of cutaneous side-effects #	10
The differential effects of upadacitinib treatment on skin rashes of four anatomical sites in patients with atopic dermatitis	10
Dupilumab as promising treatment for prurigo nodularis: current evidences	10
A consistent skin care regimen leads to objective and subjective improvements in dry human skin: investigator-blinded randomized clinical trial	10
Improvement in sleep and itch and enhanced quality of life in adult patients with moderate-to-severe atopic dermatitis: results from a phase 3 trial of baricitinib therapy	10
A prospective, split-face study comparing 1,064-nm picosecond Nd:YAG laser toning with 1,064-nm Q-switched Nd:YAG laser toning in the treatment of melasma	10
Dermoscopic evaluation of tranexamic acid versus Vitamin C, with microneedling in the treatment of melasma: a comparative, split-face, single-blinded study	10
A review of IL-36: an emerging therapeutic target for inflammatory dermatoses	10
Emerging topical therapies to treat pigmentary disorders: an evidence-based approach	10
Fractional erbium:YAG laser (2940 nm) plus topical hydroquinone compared to intradermal tranexamic acid plus topical hydroquinone for the treatment of refractory melasma: a randomized controlled trial	9
Anti-IL-23 and anti-IL-17 drugs for the treatment of non-pustular palmoplantar psoriasis: a real-life retrospective study	9
Emerging treatments for bullous pemphigoid	9
Efficacy, tolerability, patient usability, and satisfaction with a 2 mL pre-filled syringe containing secukinumab 300 mg in patients with moderate to severe plaque psoriasis: results from the phase 3	9
Eczema control and treatment satisfaction in atopic dermatitis patients treated with dupilumab – a cross-sectional study from the BioDay registry	9
Efficacy and predictive factors of cyclosporine A in alopecia areata: a systematic review with meta-analysis	9

Systematic literature review of long-term efficacy data for topical psoriasis treatments	9
Long-term maintenance treatment of psoriasis: the role of calcipotriol/betamethasone dipropionate aerosol foam in clinical practice	9
Platelet-rich plasma for genital lichen sclerosus: analysis and results of 94 patients. Are there gender-related differences in symptoms and therapeutic response to PRP?	9
Cutaneous adverse events of immune checkpoint inhibitor therapy: incidence and types of reactive dermatoses	9
The efficacy of probiotics supplementation for the treatment of atopic dermatitis in adults: a systematic review and meta-analysis	8
Managing pediatric psoriasis: update on treatments and challenges—a review	8
Drug survival of secukinumab, ustekinumab, and certolizumab pegol in psoriasis: a 2-year, monocentric, retrospective study	8
The efficacy and safety of JAK inhibitors for atopic dermatitis: a systematic review and meta-analysis	8
Network meta-analyses comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis at 24–28 and 48–52 weeks	8
Biologics recommendations for patients with psoriasis: a critical appraisal of clinical practice guidelines for psoriasis	8
Scalp hair regrowth is associated with improvements in health-related quality of life and psychological symptoms in patients with severe alopecia areata: results from two randomized controlled trials	8
Efficacy of adalimumab in pediatric generalized pustular psoriasis: case series and literature review	8
Racial and ethnic diversity of US participants in clinical trials for acne, atopic dermatitis, and psoriasis: a comprehensive review	8
Use of systemic therapies for psoriasis in the COVID-19 era	8
Liposomal azelaic acid 20% cream vs hydroquinone 4% cream as adjuvant to oral tranexamic acid in melasma: a comparative study	8
Efficacy of autologous platelet-rich plasma therapy versus topical Minoxidil in men with moderate androgenetic alopecia: a randomized open-label trial	8
Adipose-derived stem cell exosomes for treatment of dupilumab-related facial redness in patients with atopic dermatitis	8
Itraconazole versus propranolol: therapeutic and pharmacologic effect on serum angiopoietin-2 in patients with infantile hemangioma	8
Pediatric hidradenitis suppurativa: epidemiology, disease presentation, and treatments	8
Isotretinoin for acne vulgaris – an update on adverse effects and laboratory monitoring	8
Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) with probable mesentery involvement with associated hemophagocytic syndrome (HPS) – how to treat it?	7
Brodalumab efficacy in bio-naïve psoriasis patients: real-life experience of 202 subjects up to 48 weeks	7
Matching-adjusted indirect comparison of efficacy outcomes in trials of calcipotriol plus betamethasone dipropionate foam and cream formulations for the treatment of plaque psoriasis	7
Clinical and histologic features associated with lentigo maligna clearance after imiquimod treatment	7
Clinical implications and predictive values of early PASI responses to tildrakizumab in patients with moderate-to-severe plaque psoriasis	7
Efficacy and safety of dimethylfumarate in elderly psoriasis patients: a multicentric Italian study	7
Neonatal epidermolysis bullosa: lessons to learn about genetic counseling	7
Hyperhidrosis and the risk of being treated for skin infections	7
Pulsed dye laser versus intense pulsed light for facial erythema of rosacea: a systematic review and meta-analysis	7
Limb melanomas: acral melanomas have worse survival	7
A time series analysis of immune checkpoint inhibitor use in the United States Medicare population: 2014–2019	7
Real-world outcomes following switching from anti-TNF reference products to biosimilars for the treatment of psoriasis	7
Evaluating social media as a source of patient information regarding psoriasis treatments using the DISCERN instrument	7
Maintained improvement in physician- and patient-reported outcomes with baricitinib in adults with moderate-to-severe atopic dermatitis who were treated for up to 104 weeks in a randomized trial	7
Probiotics for the prevention of atopic dermatitis in infants from different geographic regions: a systematic review and Meta-analysis	7
A clinical perspective on risk factors and signs of subclinical and early psoriatic arthritis among patients with psoriasis	7
Combined chemical peels versus trichloroacetic acid (TCA) for treating melasma: a split face study	7
Exploring determinants of psoriasis patients’ treatment choices: a discrete-choice experiment study in the United States and Germany	7
Treatment preferences among patients with mild-to-moderate atopic dermatitis	7
Preliminary results on long-term follow-up of systemic sclerosis patients under extracorporeal photopheresis	7
Surgical treatment of verrucous carcinoma: a review	7
Efficacy, safety, usability, and acceptability of risankizumab 150 mg formulation administered by prefilled syringe or by an autoinjector for moderate to severe plaque psoriasis	7
Concurrent vitiligo and atopic dermatitis successfully treated with upadacitinib: a case report	7
Effectiveness of ustekinumab in patients with atopic dermatitis: analysis of real-world evidence	6
Autologous platelet-rich plasma ‘fluid’ versus ‘gel’ form in combination with fractional CO2laser in the treatment of atrophic acne scars: a split-face randomized clinical trial	6
Methotrexate dosing regimen for plaque-type psoriasis: an update of a systematic review	6
Effects of TNF-α inhibition on pre-clinical enthesitis: observational study on 49 psoriatic patients	6
The current treatment landscape in adult atopic dermatitis in the United States: results from a cross-sectional real-world study	6
A qualitative study of dermatology patients and providers to understand discordant perceptions of symptom burden and disease severity	6
Exploring the burden of xerosis cutis and the impact of dermatological skin care from patient's perspective	6
Efficacy and safety of abrocitinib for the treatment of moderate-to-severe atopic dermatitis: a meta-analysis of randomized clinical trials	6
Patient assessment of 5-fluorouracil and imiquimod for the treatment of actinic keratoses: a retrospective study of real-world effectiveness	6
A split face comparative study between intradermal tranexamic acid and Erbium-YAG laser in treatment of melasma	6
Paradoxical tralokinumab-induced psoriasis in a patient with atopic dermatitis	6
Topical rapamycin in the treatment of facial angiofibromas in tuberous sclerosis: a systematic review based on evidence	6
Pyoderma gangrenosum and Behçet’s-like disease induced by secukinumab: a paradoxical drug reaction	6
A hyaluronic acid-based micro-filler improves superficial wrinkles and skin quality: a randomized prospective controlled multicenter study	6
Exploring the potential of nanocarriers in antipsoriatic therapeutics	6
Human adipose tissue-derived MSCs improve psoriasis-like skin inflammation in mice by negatively regulating ROS	6
Treatment goals and preferences of pediatric psoriasis patients, young adults, and parents	6
Long-term efficacy and safety of secukinumab in real life: a 240 weeks multicenter study from Southern Italy	6
Clinical efficacy and safety of secukinumab for psoriasis in a real-world setting in Turkey	5
The impact of social media on dermatologists and in captivating their patients: a cross-sectional study	5
Intralesional corticosteroid injections are less painful without local anesthetic: a double-blind, randomized controlled trial	5
Treatment persistence of interleukin-17 inhibitor class drugs among patients with psoriasis in Japan: a retrospective database study	5
Successful treatment of alopecia universalis with abrocitinib: a case report	5
Deep learning-based fully automated diagnosis of melanocytic lesions by using whole slide images	5
Topical prebiotics/postbiotics and PRURISCORE validation in atopic dermatitis. International study of 396 patients	5
Efficacy and safety of abrocitinib monotherapy in adolescents and adults: a post hoc analysis of the phase 3 JAK1 atopic dermatitis efficacy and safety (JADE) REGIMEN clinical trial	5
Serum drug levels and anti-drug antibodies in the context of dose tapering by interval prolongation of adalimumab, etanercept and ustekinumab in psoriasis patients: results of the CONDOR trial	5
Initial validation of a new device for facial skin analysis	5
Prevalence, risk and severity of SARS-CoV-2 infections in psoriasis patients receiving conventional systemic, biologic or topical treatment during the COVID-19 pandemic: a cross-sectional cohort study	5
An anchored matching-adjusted indirect comparison of fixed-dose combination calcipotriol and betamethasone dipropionate (Cal/BDP) cream versus Cal/BDP foam for the treatment of psoriasis	5
Systematic review of mesotherapy: a novel avenue for the treatment of hair loss	5
Trends and risk factors in the antibiotic management of skin and soft tissue infections in the United States	5
Anti-IL-17A blockade did not significantly reduce inflammatory lesions in a placebo-controlled pilot study in adult patients with moderate to severe acne	5
Evaluation of needling/microneedling as an adjunct to phototherapy in the treatment of stable acral vitiligo: a comparative clinical and immunohistochemical study	5
Use of autologous platelet-rich plasma in androgenetic alopecia in women: a systematic review and meta-analysis	5
Data mining for detecting signals of adverse drug reaction of doxycycline using the Korea adverse event reporting system database	5
Disease response and patient-reported outcomes among initiators of ixekizumab	5

Burden of adult atopic dermatitis and unmet needs with existing therapies	5
RETRACTED ARTICLE: Secukinumab-induced paradoxical skin lesions, but successful treatment with tofacitinib in SAPHO syndrome: a case report	5
Efficacy of tralokinumab after failure with upadacitinib and dupilumab in a patient affected by atopic dermatitis	5
Emerging systemic therapies for atopic dermatitis: biologics	5
Treatment of tardive dyskinesia: a review and update for dermatologists managing delusions of parasitosis	5
Dermoscopy-guided Mohs micrographic surgery in post-laser basal cell carcinomas: is dermoscopy helpful for demarcation of the surgical margin?	5
Evaluation of HLA class I and HLA class II allele profile and its relationship with clinical features in patients with alopecia areata: a case–control study	5
Treatment of generalized granuloma annulare with dupilumab	5
Patient preferences for atopic dermatitis treatments: a discrete choice experiment	5
Treatment satisfaction of patients with psoriasis with topical therapy in a real-world setting: unmet need for higher effectiveness	5
Photodynamic therapy combined with surgery versus Mohs micrographic surgery for the treatment of difficult-to-treat basal cell carcinoma: a retrospective clinical study	5
Safety of anti-IL-23 drugs in patients with moderate-to-severe plaque psoriasis and previous tuberculosis infection: a monocentric retrospective study	5
Upadacitinib for the treatment of atopic dermatitis in the elderly: an Italian case series of seven patients	5
Effectiveness of switching from baricitinib 4 mg to upadacitinib 30 mg in patients with moderate-to-severe atopic dermatitis: a real-world clinical practice in Japan	5
Drug survival analysis of dupilumab and cyclosporin in patients with atopic dermatitis: a multicenter study	5
Real-world treatment patterns and healthcare costs in patients with psoriasis taking systemic oral or biologic therapies	5
Efficacy of biologics and oral small molecules for atopic dermatitis: a systematic review and meta-analysis	5
Potential use of microwave technology in dermatology	5
Tofacitinib in the treatment of refractory eczemas – a case series	5